NCT04621396 The Next Generation Longitudinal Birth Cohort Diabetes Study
| NCT ID | NCT04621396 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Type 2 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2013-09 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2013-09 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of this project is to understand the independent roles of maternal factors, intrauterine exposures, genetic factors, and postnatal environment on the development of obesity and youth-onset type 2 diabetes (T2D) in childhood.
Eligibility Criteria
Inclusion Criteria: * Pregnant women with type 2 diabetes, gestational diabetes, or no diabetes. * From self-identified Indigenous heritage (e.g., Cree, Oji-Cree, Métis, Anishinaabe, etc.). * Are delivering and residing in Manitoba. * Mother/Father and children must be biological family members. Exclusion Criteria: * Mothers or children with type 1 diabetes. * Residing outside of Manitoba.
Contact & Investigator
Brandy A Wicklow, MD, MSc
PRINCIPAL INVESTIGATOR
University of Manitoba, Children's Hospital Research Institute of Manitoba
Frequently Asked Questions
Who can join the NCT04621396 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04621396 currently recruiting?
Yes, NCT04621396 is actively recruiting participants. Contact the research team at bwicklow@hsc.mb.ca for enrollment information.
Where is the NCT04621396 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT04621396 clinical trial?
NCT04621396 is sponsored by University of Manitoba. The principal investigator is Brandy A Wicklow, MD, MSc at University of Manitoba, Children's Hospital Research Institute of Manitoba. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.